These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 33246603
1. The relationship between stereochemical and both, pharmacological and ADME-Tox, properties of the potent hydantoin 5-HT7R antagonist MF-8. Kucwaj-Brysz K, Latacz G, Podlewska S, Żesławska E, Handzlik J, Lubelska A, Satała G, Nitek W, Handzlik J. Bioorg Chem; 2021 Jan; 106():104466. PubMed ID: 33246603 [Abstract] [Full Text] [Related]
3. Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation. Kucwaj-Brysz K, Warszycki D, Podlewska S, Witek J, Witek K, González Izquierdo A, Satała G, Loza MI, Lubelska A, Latacz G, Bojarski AJ, Castro M, Kieć-Kononowicz K, Handzlik J. Eur J Med Chem; 2016 Apr 13; 112():258-269. PubMed ID: 26900658 [Abstract] [Full Text] [Related]
4. MF-8, a novel promising arylpiperazine-hydantoin based 5-HT7 receptor antagonist: In vitro drug-likeness studies and in vivo pharmacological evaluation. Latacz G, Lubelska A, Jastrzębska-Więsek M, Partyka A, Kucwaj-Brysz K, Wesołowska A, Kieć-Kononowicz K, Handzlik J. Bioorg Med Chem Lett; 2018 Mar 01; 28(5):878-883. PubMed ID: 29439902 [Abstract] [Full Text] [Related]
7. Unlocking the potential of higher-molecular-weight 5-HT7R ligands: Synthesis, affinity, and ADMET examination. Pyka P, Garbo S, Murzyn A, Satała G, Janusz A, Górka M, Pietruś W, Mituła F, Popiel D, Wieczorek M, Palmisano B, Raucci A, Bojarski AJ, Zwergel C, Szymańska E, Kucwaj-Brysz K, Battistelli C, Handzlik J, Podlewska S. Bioorg Chem; 2024 Oct 01; 151():107668. PubMed ID: 39079393 [Abstract] [Full Text] [Related]
8. Isoindol-1-one analogues of 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridyl)-p-iodobenzamido]ethyl]pipera zine (p-MPPI) as 5-HT1A receptor ligands. Zhuang ZP, Kung MP, Mu M, Kung HF. J Med Chem; 1998 Jan 15; 41(2):157-66. PubMed ID: 9457239 [Abstract] [Full Text] [Related]
14. Discovery of G Protein-Biased Antagonists against 5-HT7R. Kwag R, Lee J, Kim D, Lee H, Yeom M, Woo J, Cho Y, Kim HJ, Kim J, Keum G, Jeon B, Choo H. J Med Chem; 2021 Sep 23; 64(18):13766-13779. PubMed ID: 34519505 [Abstract] [Full Text] [Related]
18. Novel anilide and benzylamide derivatives of arylpiperazinylalkanoic acids as 5-HT1A/5-HT7 receptor antagonists and phosphodiesterase 4/7 inhibitors with procognitive and antidepressant activity. Jankowska A, Satała G, Kołaczkowski M, Bucki A, Głuch-Lutwin M, Świerczek A, Pociecha K, Partyka A, Jastrzębska-Więsek M, Lubelska A, Latacz G, Gawalska A, Bojarski AJ, Wyska E, Chłoń-Rzepa G. Eur J Med Chem; 2020 Sep 01; 201():112437. PubMed ID: 32673902 [Abstract] [Full Text] [Related]
19. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists. Liu KG, Robichaud AJ, Bernotas RC, Yan Y, Lo JR, Zhang MY, Hughes ZA, Huselton C, Zhang GM, Zhang JY, Kowal DM, Smith DL, Schechter LE, Comery TA. J Med Chem; 2010 Nov 11; 53(21):7639-46. PubMed ID: 20932009 [Abstract] [Full Text] [Related]
20. Synthesis and pharmacological evaluation of aryl aminosulfonamide derivatives as potent 5-HT(6) receptor antagonists. Nirogi RV, Daulatabad AV, Parandhama G, Mohammad S, Sastri KR, Shinde AK, Dubey PK. Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4440-3. PubMed ID: 20594839 [Abstract] [Full Text] [Related] Page: [Next] [New Search]